Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 14, 2014; 20(34): 12118-12131
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12118
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12118
Early detection and prevention of pancreatic cancer: Is it really possible today?
Marco Del Chiaro, Ralf Segersvärd, Matthias Löhr, Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, 141 86 Stockholm, Sweden
Caroline Verbeke, Division of Pathology, Department of Laboratory Medicine, Karolinska Institute, 141 86 Stockholm, Sweden
Author contributions: Del Chiaro M and Verbeke C designed research and wrote the paper; Segersvärd R and Löhr M contributed to the research.
Correspondence to: Marco Del Chiaro, MD, PhD, Associate Professor of Surgery, Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, 141 86 Stockholm, Sweden. marco.del-chiaro@karolinska.se
Telephone: +46-85-8580000 Fax: +46-85-8586366
Received: December 28, 2013
Revised: January 23, 2014
Accepted: May 29, 2014
Published online: September 14, 2014
Processing time: 264 Days and 19.6 Hours
Revised: January 23, 2014
Accepted: May 29, 2014
Published online: September 14, 2014
Processing time: 264 Days and 19.6 Hours
Core Tip
Core tip: Pancreatic cancer is the 4th leading cause of cancer-related death in Western countries. Considering the low incidence of pancreatic cancer, population-based screening is not feasible. This review analyzes the possibility to identify a population at risk for pancreatic cancer and the strategies for clinical screening and prevention.